Tag: continuous blood glucose monitor
Glucotrack receives patent allowance for implantable CBGM platform
July 9, 2026HME News Staff
RUTHERFORD, N.J. – Glucotrack has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent application covering its implantable continuous blood glucose monitoring platform. The application, titled “Methods and Systems for Continuously Monitoring the Glucose Level of a Patient,” expands intellectual property protection for the company’s fully implantable CBGM system as it advances toward commercialization. The filing follows three CBGM patents...
Glucotrack, OneTwo Analytics AB seek to 'revolutionize’ diabetes management
April 7, 2025HME News Staff
RUTHERFORD, N.J., and STOCKHOLM – A new agreement with OneTwo Analytics AB will allow Glucotrack to leverage next-generation artificial intelligence and machine learning-based analytics to evaluate clinical study data from its continuous blood glucose monitors. “OneTwo Analytics are experts in simplifying complex diabetes data to generate simple, clear insights empowering clinics, health care professionals, and individuals with diabetes to make better informed decisions,” said Paul...